Skip to main content
High RiskFDAfda-F-0206-2023OTHER

Red Button Vintage Creamery French Silk Pie, Net Wt. 31.88 oz. (904g), in a clear plastic dome and black plastic base, UPC 0 41172 81290 ...

Category
Units Affected
1,116
Recall Date
November 28, 2022
Issuing Agency
Hazard
Other

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0206-2023.

Pies labeled as Red Button French Silk may contain Turtle Cream Pies containing almonds which are not declared on the French Silk label.

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0206-2023.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Rocky Mountain Pies, Llc or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0206-2023.

Rocky Mountain Pies, LLC

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Rocky Mountain Pies, Llc Recall FAQ

Rocky Mountain Pies, Llc is the subject of a food safety report: Red Button Vintage Creamery French Silk Pie, Net Wt. 31.88 oz. (904g), in a clear plastic dome and black plastic base, UPC 0 41172 81290 .... The notice was published on November 28, 2022 by the U.S. Food and Drug Administration (FDA). Approximately 1,116 units are potentially affected.